Biscayne NeuroTherapeutics
Biscayne Neurotherapeutics is a clinical-stage biotechnology company which develops novel drugs for central nervous system disorders.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Biscayne NeuroTherapeutics Information
Biscayne NeuroTherapeutics was acquired by
Supernus Pharmaceuticals.
The acquisition happend on 2018-09-14.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Miami
State: Florida
Zip:
Country: United States
Financial Info
Stage:
series b
Raised Last:
$3M
Raised Total:$3M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Biscayne Neurotherapeutics is a clinical-stage biotechnology company developing novel therapies for difficult-to-treat neurological disorders. Biscayne’s lead compound, BIS-001, is in clinical development for the treatment of refractory forms of epilepsy. Biscayne Neurotherapeutics has an experienced executive team with an extensive track record of successful drug development, and its scientific advisors include a number of highly respected experts studying seizure and other CNS disorders. The company is headquartered in Miami, Florida, and benefits from the growing entrepreneurial South Florida biomedical sector.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2017 | Series B | 2 | $3M |
Mesa Verde Venture Partners Quark Venture Mesa Verde Venture Partners Quark Venture |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
